Medical devices; hematology and pathology devices; classification of the Factor V Leiden DNA mutation detection systems devices. Final rule.
The Food and Drug Administration (FDA) is classifying the Factor V Leiden deoxyribonucleic acid (DNA) mutation detections systems device into class II (special controls). The special control that will apply to the device is the guidance document entitled "Class II Special Controls Guidance Document: Factor V Leiden DNA Mutation Detection Systems." The agency is taking this action in response to a petition submitted under the Federal Food, Drug, and Cosmetic Act (the act) as amended by the Medical Device Amendments of 1976 (the 1976 amendments), the Safe Medical Devices Act of 1990 (SMDA), the Food and Drug Administration Modernization Act of 1997 (FDAMA), and the Medical Device User Fee and Modernization Act of 2002. The agency is classifying this device into class II (special controls) in order to provide a reasonable assurance of safety and effectiveness of the device. Elsewhere in this issue of the Federal Register, FDA is publishing a notice of availability of a guidance document that is the special control for this device.
D018795:Device Approval / Q000331:legislation & jurisprudence; D004867:Equipment Design; D004869:Equipment Safety / Q000145:classification*; D005165:Factor V / Q000145:classification / Q000235:genetics*; D005821:Genetic Techniques / Q000145:classification / Q000295:instrumentation*; D005820:Genetic Testing / Q000145:classification / Q000331:legislation & jurisprudence; D006405:Hematology / Q000145:classification / Q000295:instrumentation*; D006801:Humans; D010336:Pathology / Q000145:classification / Q000295:instrumentation*; D017354:Point Mutation / Q000235:genetics*; D011933:Reagent Kits, Diagnostic / Q000145:classification; D019851:Thrombophilia / Q000097:blood / Q000235:genetics*; D014481:United States; D014486:United States Food and Drug Administration
D011933:Reagent Kits, Diagnostic; D005165:Factor V